Human SNP ID | rs6436839 |
---|---|
Human chromosome | chr2 |
Human SNP position | 229105082 |
Pig chromosome | chr15 |
Pig SNP position | 144198486 |
PubMed ID | 21107309 |
---|---|
Journal | Neuropsychopharmacology |
Link | www.ncbi.nlm.nih.gov/pubmed/21107309 |
Study | Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia. |
Disease/Trait | Response to antipsychotic treatment in schizophrenia (reasoning) |
Initial sample | 738 European ancestry, African American, and other ancestry cases |
Replication sample | NA |
Region | 2q36.3 |
Chromosome id | chr2 |
Chromosome position | 229105082 |
Reported gene | PID1 |
Mapped gene | PID1 |
Upstream gene id | |
Downstream gene id | |
SNP gene ids | 55022 |
Upstream gene distance | |
Downstream gene distance | |
SNP risk allele | rs6436839-? |
SNPs | rs6436839 |
Merged | 0 |
SNP id current | 6436839 |
Context | intron_variant |
Intergenic | 0 |
Allele frequency | 0.29 |
P value | 0.000003 |
Pvalue mlog | 5.52287874528033 |
P value text | (quetiapine) |
Or beta | |
%95 Ci | |
Platform | Affymetrix [492900] |
CNV | N |
Mapped trait | reasoning |
Mapped trait URI | http://www.ebi.ac.uk/efo/EFO_0004350 |
Study accession | GCST000885 |